Prosecution Insights
Last updated: August 14, 2026

LifeNet Health

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (50%)
3
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (17%)
§102 only1 (17%)
Double-patenting + other1 (17%)
Multi-statute (no §101)3 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BERKE-SCHLESSEL, DAVID W 1 66.6% +31.9%
HERBERT, MADISON TAYLOR 1 55.0% +56.3%
JOHNSON, ALLISON MARIE 1 45.0% +49.4%
DUDDEN, TERESA MARIE 1 46.2% +48.3%
BATES, KEENAN ALEXANDER 1 44.8% +76.5%
STAVROU, CONSTANTINA E 1 44.2% +36.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL JOHNSON, ALLISON MARIE 62d
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES HERBERT, MADISON TAYLOR
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES BATES, KEENAN ALEXANDER

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL JOHNSON, ALLISON MARIE 62d
18757079 CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF BERKE-SCHLESSEL, DAVID W
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES HERBERT, MADISON TAYLOR
17636244 TRANSFORAMINAL POSTERIOR ATRAUMATIC LUMBAR BIO-IMPLANT DUDDEN, TERESA MARIE
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES BATES, KEENAN ALEXANDER
17603661 BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF STAVROU, CONSTANTINA E

Top Art Units

Art UnitApps
1651 1
1758 1
1638 1
3774 1
1631 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18757079 CROSSLINKED SOFT TISSUE GRAFT AND METHODS OF USE THEREOF BERKE-SCHLESSEL, DAVID W 1651 §112DP Non-Final OA Pending Jun 27, 2024
17987257 CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES HERBERT, MADISON TAYLOR 1758 §102§103 Final Rejection Pending Nov 15, 2022
17731616 PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL JOHNSON, ALLISON MARIE 1638 §102§103§112 Non-Final OA 62d Pending Apr 28, 2022
17636244 TRANSFORAMINAL POSTERIOR ATRAUMATIC LUMBAR BIO-IMPLANT DUDDEN, TERESA MARIE 3774 §103 Non-Final OA Pending Feb 17, 2022
17506140 MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES BATES, KEENAN ALEXANDER 1631 §103§112 Non-Final OA Pending Oct 20, 2021
17603661 BIRTH TISSUE-DERIVED PRODUCTS AND PREPARATION AND USES THEREOF STAVROU, CONSTANTINA E 1632 §102 Final Rejection Pending Oct 14, 2021

Managing LifeNet Health's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month